AMPOLGEN PHARMACEUTICALS
Live / Registered — Registered and renewed (as of 10 Jan 2026)
What this means for you
Registered since 12 Sept 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Sept 2026).
Record
- Serial number
- 78388886
- Registration number
- 3142996
- Mark type
- Stylized text
- Filed
- 23 Mar 2004
- Published for opposition
- 30 Aug 2005
- Registered
- 12 Sept 2006
- Next maintenance due
- 12 Sept 2026
Goods and services
- Class 035 — Advertising and business services: Distributorships in the field of pharmaceuticals
- Class 042 — Scientific and technological services: Pharmaceutical drug development services
Owner
- Ampolgen Pharmaceuticals, LLC, Houston, TX, US
- Ampolgen Pharmaceuticals, LLC, Houston, TX, US
- Ampolgen Pharmaceuticals, LLC, Houston, TX, US
Prosecution history
- 10 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 10 Jan 2026 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 10 Jan 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Sept 2025 — TEAS SECTION 8 & 9 RECEIVED
- 12 Sept 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Nov 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Nov 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Nov 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Nov 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Aug 2016 — TEAS SECTION 8 & 9 RECEIVED
- 12 Sept 2015 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Sept 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 24 Sept 2012 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 24 Sept 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL